# FDA 483 - Dxn Pharmaceutical Sdn Bhd - March 06, 2026

Source: https://www.keypedia.com/records/483/dxn-pharmaceutical-sdn-bhd/4b5385ac-04c9-4900-9451-a13e0b86f1e9

> FDA 483 for Dxn Pharmaceutical Sdn Bhd on March 06, 2026. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Dxn Pharmaceutical Sdn Bhd
- Inspection Date: 2026-03-06
- Product Type: other
- Office Name: Office of Partnerships
- Summary: DXN Pharmaceutical Sdn Bhd, a dietary supplement manufacturer, was inspected and cited for deficiencies in its master manufacturing records. The records failed to include complete descriptions of all packaging materials, specifically desiccant packets, for its dietary supplement products, indicating a lack of control over consistent packaging.

## Related Officers

- [Jackson Y. See](https://www.keypedia.com/people/jackson-y-see/f0f4e260-8625-4dda-823d-55e4b4ff4ce7)

Company: https://www.keypedia.com/companies/dxn-pharmaceutical-sdn-bhd/c7a778e2-40f8-41a1-af4d-c632a3b04a1d

Office: https://www.keypedia.com/offices/office-of-partnerships/83acc701-fc5a-4876-bb34-7499e31541d3